UBS Group’s GlucoTrack GCTK Stock Holding History

UBS Group’s Portfolio GCTK Stock Details GCTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$12.9K	Buy	3,946 +3,501	+787%	+$33.4K	﹤0.01%	8865
2026 Q2	$4.26K	Buy	445 +422	+1,835%	+$7.94K	﹤0.01%	9071
2026 Q1	$456	Buy	23 +19	+475%	+$1.21K	﹤0.01%	9884
2025 Q4	$461	Buy	4 +3	+300%	+$534	﹤0.01%	9951
2025 Q3	$263	Buy	+1	New	+$181	﹤0.01%	9771
2025 Q2	–	Hold	0	–	–	–	10169
2025 Q1	–	Hold	0	–	–	–	10402
2024 Q4	–	Hold	0	–	-$7.44K	–	10094
2024 Q3	–	Hold	0	–	–	–	7908
2024 Q2	–	Hold	0	–	–	–	7607
2024 Q1	–	Hold	0	–	-$1.26K	–	9564
2023 Q4	–	Hold	0	–	–	–	8360
2023 Q3	–	Hold	0	–	–	–	9123
2023 Q2	–	Hold	0	–	–	–	8337
2022 Q1	–	Hold	0	–	-$3K	–	10472
2021 Q4	–	Hold	0	–	–	–	9655

Other funds holding GCTK

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return

UBS Group's GCTK Position: Q3 2026 in Review

UBS Group increased its GlucoTrack (GCTK) stake by 787% in Q3 2026, buying an estimated $33.4K and bringing the position to 3,946 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #8865.

UBS Group first reported a position in GCTK in Q3 2025 and has held it in 5 quarters since. 4 funds tracked by Wall St. Rank hold GCTK as of Q3 2026.

UBS Group held 3,946 shares of GlucoTrack worth $12.9K as of Q3 2026.
UBS Group bought 3,501 GlucoTrack shares in Q3 2026, an estimated $33.4K.
GlucoTrack made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #8865 holding.
UBS Group first reported a position in GlucoTrack in Q3 2025 and has held it in 5 quarters since.
4 funds tracked by Wall St. Rank held GlucoTrack as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.